Sale!

BIN1 Gene Centronuclear Myopathy Type 2 Genetic Test

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The BIN1 Gene Centronuclear Myopathy Type 2 Genetic Test is a specialized diagnostic procedure designed to identify mutations in the BIN1 gene, which are linked to the development of Centronuclear Myopathy Type 2, a rare genetic disorder characterized by muscle weakness and structural abnormalities in muscle cells. This condition is inherited in an autosomal recessive manner, meaning that an individual must inherit two copies of the mutated gene, one from each parent, to be affected.

Performed at DNA Labs UAE, this genetic test involves analyzing the patient’s DNA, extracted from a blood sample or cheek swab, to look for specific mutations in the BIN1 gene that are known to cause the disease. The test is crucial for confirming the diagnosis, understanding the disease’s progression, and guiding treatment decisions. It can also provide valuable information for family planning and genetic counseling for families affected by Centronuclear Myopathy Type 2.

The cost of the BIN1 Gene Centronuclear Myopathy Type 2 Genetic Test at DNA Labs UAE is 4400 AED. Given the complexity of the test and the expertise required to interpret the results accurately, this price reflects the specialized nature of the genetic testing process. Patients considering this test are advised to consult with a genetic counselor or a healthcare provider specializing in genetic disorders to discuss the implications of the test results and the next steps in the management of the condition.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

BIN1 Gene Centronuclear Myopathy Type 2 Genetic Test

At DNA Labs UAE, we offer the BIN1 Gene Centronuclear Myopathy Type 2 Genetic Test for AED 4400.0. This test is used to diagnose and identify mutations in the BIN1 gene that cause centronuclear myopathy type 2.

Test Components and Price

  • Components: BIN1 Gene Centronuclear Myopathy Type 2 Genetic Test
  • Price: 4400.0 AED

Sample Condition and Report Delivery

The sample condition required for this test is blood or extracted DNA. Alternatively, one drop of blood on an FTA card can also be used. The report will be delivered within 3 to 4 weeks.

Test Method and Type

  • Method: NGS Technology
  • Test Type: Neurological Disorders

Referring Doctor and Test Department

  • Doctor: Neurologist
  • Test Department: Genetics

Pre Test Information

Prior to undergoing the BIN1 Gene Centronuclear Myopathy Type 2 Genetic Test, it is important to provide the clinical history of the patient. Additionally, a genetic counseling session will be conducted to draw a pedigree chart of family members affected with BIN1 Gene Centronuclear Myopathy Type 2.

Test Details

Centronuclear myopathy type 2 is a rare genetic disorder that affects the muscles. It is caused by mutations in the BIN1 gene, which provides instructions for making a protein important for the proper function of muscle cells. Symptoms of this disorder include muscle weakness, particularly in the muscles used for movement and breathing.

NGS genetic testing can be used to identify mutations in the BIN1 gene associated with centronuclear myopathy type 2. This test involves analyzing a patient’s DNA to look for changes in the gene sequence. A positive identification of a mutation in the BIN1 gene can provide a definitive diagnosis for centronuclear myopathy type 2, allowing for appropriate medical management and genetic counseling.

In addition, genetic testing can help identify individuals who may be at risk for the disorder, enabling early intervention and treatment.

Test Name BIN1 Gene Centronuclear myopathy type 2 Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card o
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Neurological Disorders
Doctor Neurologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for BIN1 Gene Centronuclear myopathy type 2 NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with BIN1 Gene Centronuclear myopathy type 2
Test Details

Centronuclear myopathy type 2 is a rare genetic disorder that affects the muscles. It is caused by mutations in the BIN1 gene, which provides instructions for making a protein that is important for the proper function of muscle cells. This disorder is characterized by muscle weakness, particularly in the muscles used for movement and breathing.

NGS genetic testing can be used to identify mutations in the BIN1 gene that cause centronuclear myopathy type 2. This test involves analyzing a patient’s DNA to look for changes in the gene sequence that are associated with the disorder.

Identification of a mutation in the BIN1 gene can provide a definitive diagnosis for centronuclear myopathy type 2 and allow for appropriate medical management and genetic counseling. Additionally, genetic testing can help identify individuals who may be at risk for the disorder and allow for early intervention and treatment.